Riskpilot← Back to searchSign inGet full accessTD Läkarkonsult AB
ABActiveOrg 5568302896Lorensbergsgatan 21General medical practice activities · NACE 8621Est. 20101 employees
Revenue 2025
SEK 0
EBITDA margin
—
-267% vs 2024
Equity ratio
91.6%
Financial strength
Net profit 2025
SEK -179K
-16654% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -376K | -267% |
| Net profit | SEK -179K | -16654% |
| Total assets | SEK 2,2M | -10% |
| Equity | SEK 2M | -8% |
| Employees | 1 | — |
Legal name
TD Läkarkonsult AB
Org number
5568302896
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 december 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att endera vara underentreprenör till bemanningsföretag, alternativt själv åta sig konsultuppdrag eller föreläsningsuppdrag gentemot uppdragsgivare, i första hand, inom sjukvård. Därutöver förvalta och bedriva handel med värdepapper samt äga och förvalta fast egendom och därmed förenlig verksamhet.
Address
Lorensbergsgatan 21
Email
tcgdavidsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 687 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | −67 | −341 |
| EBITDA | −310 | −280 | −207 | −102 | −376 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −310 | −280 | −207 | −102 | −376 |
| Net financials | 598 | 327 | 62 | 50 | 127 |
| Profit before tax | 216 | 127 | 7 | 3 | −179 |
| Tax | −45 | −28 | −5 | −2 | — |
| Net profit | 171 | 99 | 2 | 1 | −179 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 965 | 2 506 | 2 449 | 2 391 | 2 160 |
| Equity | 2 357 | 2 206 | 2 158 | 2 159 | 1 979 |
| Long-term debt | 0 | 0 | 150 | 150 | 170 |
| Short-term debt | 252 | 24 | 17 | 13 | 11 |
| Total debt | 252 | 24 | 167 | 163 | 181 |
EBITDA margin
-37556000.0%
This company
15.8%
Market median
-237696303% vs market
20212025
Equity ratio
91.6%
This company
38.2%
Market median
+140% vs market
20212025
Return on equity
-9.1%
This company
18.4%
Market median
-149% vs market
20212025
Net profit margin
-17944000.0%
This company
8.1%
Market median
-221530964% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TD Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carina Birgitta Davidsson | Deputy Board Member | 0 companies |
| Tom Carl Gustaf Davidsson | Board of Directors | 0 companies |